Tekla Life Sciences Investors
HQL · Financial Services · $586M
$20.21+1.56%
Price
$17.95
$20.21
May 7, 26Aug 6, 26
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue$48M+313.2%
Operating Income$65M-50.8%
Net Income$65M-50.8%
9/'25 vs prev quarter
Company Health
Operating Margin+187.5%
Cash on Hand$851,602
PSR7.3x
PER3.1x
PBR1.0x
ROE+33.2%
